Renal Cell Carcinoma Metastatic

18 clinical trials · Condition

Record	Firm	Date
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma (NCT05103722)	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	2022-02-17
A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line (NCT04764487)	Weprom	2021-06-07
TDM for Optimized Outcome in Patients With mRCC. (NCT04659343)	Niels Fristrup	2020-11-01
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial (NCT03977571)	Niels Fristrup	2020-07-06
High Dose IL-2 in Combination With Anti-PD-1 (NCT03991130)	Gregory Daniels	2019-07-17
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma (NCT03905889)	Brown University	2019-06-05
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC (NCT03699579)	Ipsen	2019-02-22
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer (NCT06377722)	Fundacion Oncosur	2018-11-01
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy (NCT03013946)	AIO-Studien-gGmbH	2017-01-18
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) (NCT02974738)	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	2016-12-07
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) (NCT02432846)	Mendus	2015-04-01

Track Renal Cell Carcinoma Metastatic automatically

Every clearance here is in the API, with alerts when new ones post.